Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value
$509.48M
Total Bought
$509.48M
Total Sold
$284.15M
Net Transaction
+$225.33M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
AMBRX BIOPHARMA INC016,688,636+16,688,6360237,64646.64%+237,646
TG THERAPEUTICS INC(TGTX)04,046,598+4,046,598069,11613.57%+69,116
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)01,039,289+1,039,289062,76312.32%+62,763
CYTOKINETICS INC(CYTK)0600,000+600,000050,0949.83%+50,094
KEROS THERAPEUTICS INC(KROS)01,060,427+1,060,427042,1638.28%+42,163
VAXCYTE INC(PCVX)0579,959+579,959036,4217.15%+36,421
SPRINGWORKS THERAPEUTICS INC0192,734+192,73407,0351.38%+7,035
NUVALENT INC057,698+57,69804,2460.83%+4,246
ARGENX SE(ARGX)45,6150-45,61522,4260—-22,426
IMMUNOVANT INC(IMVT)1,818,3710-1,818,37169,8070—-69,807
AMBRX BIOPHARMA INC16,688,6360-16,688,636191,9190—-191,919
Page 1 of 1
Darwin Global Management, Ltd. — 13F Holdings — Q4 2023 | TickerTrail